Armando Santoro, MD
U.O. Ematologia - Istituto Clinico Humanitas - Rozzano - ITALY · Istituto Clinico Humanitas · IRCCS Instituto Clinic Humanitas
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Armando Santoro, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:01 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT05300282 · Study of Atezolizumab Plus BEGEV Regimen in Relapsed or Refractory Hodgkin's Lymphoma PatientsFondazione Italiana Linfomi - ETS · active not recruiting · Relapsed or Refractory Hodgkin's Lymphoma · principal investigator
- Ph1/Ph2NCT03943043 · Gemcitabine + Oxaliplatin +Nab-paclitaxel in Subjects With Advanced Biliary Tract CancerIstituto Clinico Humanitas · unknown · Cholangiocarcinoma · principal investigator
- Ph1NCT03850067 · A Safety, Tolerability and Preliminary Efficacy Evaluation of CC-90011 Given in Combination With Cisplatin and Etoposide in Subjects With First Line, Extensive Stage Small Cell Lung CancerCelgene · completed · Small Cell Lung Carcinoma · principal investigator
- Ph2NCT03109886 · Study of Milciclib in Patients With Unresectable/Metastatic Hepatocellular CarcinomaTiziana Life Sciences LTD · completed · Hepatocellular Carcinoma · principal investigator
- Ph2NCT02956889 · To Assess The Efficacy And Safety Of Vismodegib And Radiotherapy In Advanced Basal Cell CarcinomaIstituto Clinico Humanitas · terminated · Carcinoma, Basal Cell · principal investigator
- Ph2NCT02307500 · Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard TherapyIstituto Clinico Humanitas · completed · Pancreas Cancer, Ovarian Cancer, Melanoma · principal investigator
- Ph2NCT02303899 · Combination of Gemcitabine and Imatinib Mesylate in Pemetrexed-pretreated Patients With Pleural MesotheliomaIstituto Clinico Humanitas · completed · Mesothelioma, Malignant · principal investigator
- N/ANCT02300883 · Observational Prospective Analysis of Biological Characteristics of Mesothelioma PatientsArmando Santoro, MD · completed · Malignant Mesothelioma · principal investigator
- Ph2NCT02113553 · Anti-Mullerian Hormone (AMH) as Marker of Ovarian ReserveArmando Santoro, MD · terminated · Breast Cancer · principal investigator
- Ph2NCT02049047 · Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With ChemotherapyArmando Santoro, MD · completed · Thymoma and Thymic Carcinoma · principal investigator
- Ph1/Ph2NCT02049060 · Study of the Combination of Tivantinib Plus Pemetrexed and CarboplatinArmando Santoro, MD · completed · Malignant Pleural Mesothelioma, Nonsquamous Nonsmall Cell Neoplasm of Lung · principal investigator
- N/ANCT01891578 · Evaluation of Immunological Reconstitution After Haploidentical Bone Marrow TransplantationArmando Santoro, MD · unknown · Lymphoma · principal investigator
- Ph2NCT01884441 · Bendamustine, Gemcitabine and Vinorelbine (BeGEV) as Induction Therapy in Relapsed/Refractory Hodgkin's Lymphoma PatientsArmando Santoro, MD · unknown · Hodgkin's Lymphoma · principal investigator
- Ph1NCT01884428 · Study of Combination of PIGEV Before Autologous Stem Cell Transplant in Patients With Hodgkin's LymphomaArmando Santoro, MD · unknown · Hodgkin's Lymphoma · principal investigator
- N/ANCT01865045 · Pharmacogenetics Of Vinorelbine In Malignant Pleural Mesothelioma PatientsArmando Santoro, MD · completed · Malignant Pleural Mesothelioma · principal investigator
- Ph2NCT01681563 · Trial of Pentostatin Plus Cyclophosphamide With Ofatumumab (PCO) in Older Patients With Chronic Lymphocytic LeukemiaNiguarda Hospital · completed · Chronic Lymphocytic Leukemia · principal investigator
- N/ANCT01193959 · Pemetrexed in Advanced Non-small Cell Lung CancerArmando Santoro, MD · completed · Non-small Cell Lung Cancer (NSCLC) · principal investigator
- N/ANCT01163058 · Tyrosine Kinase Inhibitors In Metastatic Non Small Cell Lung CancerIstituto Clinico Humanitas · unknown · Non Small Cell Lung Cancer · principal investigator
- Ph2NCT01068132 · Prognostic Factors for Patients With Advanced Colorectal Cancer Treated With Cetuximab.Regione Lombardia · completed · Colorectal Cancer · principal investigator
- Ph2NCT01034878 · Sunitinib in Metastatic Renal CancerIstituto Clinico Humanitas · completed · Carcinoma, Renal Cell · principal investigator
- Ph1NCT00984425 · The Treatment of Lapatinib in Combination With Sorafenib in Patients With Advanced Refractory Solid TumorsIstituto Clinico Humanitas · completed · Solid Tumors · principal investigator
- Ph2NCT00971685 · The Treatment of Lenalidomide in Patients With POEMS SyndromeIstituto Clinico Humanitas · unknown · POEMS Syndrome · principal investigator
- N/ANCT00969098 · Response Evaluation in Malignant Pleural MesotheliomaIstituto Clinico Humanitas · unknown · Malignant Pleural Mesothelioma · principal investigator
- N/ANCT00965627 · Biology of Thymic TumorsIstituto Clinico Humanitas · completed · Thymoma · principal investigator
- N/ANCT00879528 · Consolidation PET-based and Donor-based After Salvage Therapy in Patients With HL in Relapse or RefractoryFondazione Italiana Linfomi - ETS · terminated · Hodgkin's Lymphoma · study director
- N/ANCT00874146 · Level of HER2-neu Gene Amplification an Response to TrastuzumabIstituto Clinico Humanitas · unknown · Advanced Breast Cancer · principal investigator
- N/ANCT00867711 · Molecular Predictors of Pemetrexed and Carboplatin Response in Malignant Pleural Mesothelioma (MPM) PatientsIstituto Clinico Humanitas · completed · MALIGNANT PLEURAL MESOTHELIOMA · principal investigator
- N/ANCT00831454 · Identification of EGFR-TKIs Sensitivity or Resistance Markers in NSCLC May Help in Optimal Patient SelectionArmando Santoro, MD · completed · NON-SMALL-CELL LUNG CANCER · principal investigator
- Ph3NCT00807066 · Randomized Gefitinib TrialFondazione Humanitas per la Ricerca · completed · Non Small Cell Lung Cancer · principal investigator
- N/ANCT00763607 · Retrospective Study Evaluating IGF1R And p95HER2 as Prognostic Factors in Non Small Cell Lung Cancer (NSCLC)Armando Santoro, MD · completed · Non Small Cell Lung Cancer · principal investigator
- Ph2NCT00758134 · Trastuzumab Therapy in Non-Small Cell Lung Cancer PatientsArmando Santoro, MD · terminated · NON-SMALL CELL LUNG CANCER · principal investigator
- Ph2NCT00754364 · Mono Versus Polichemotherapy in Non Small Cell Lung Cancer (NSCLC) Elderly PatientsArmando Santoro, MD · terminated · NSCLC · principal investigator
- N/ANCT00740532 · Molecular Features Predicting Response/Resistance to Trastuzumab in Metastatic Breast Cancer PatientsIstituto Clinico Humanitas · completed · Breast Cancer · principal investigator
- Ph1/Ph2NCT00697476 · Study of Oral Vorinostat in Combination With Topotecan in Patients With Chemosensitive Recurrent SCLCArmando Santoro, MD · terminated · Small Cell Lung Cancer · principal investigator
- Ph3NCT00637325 · Trastuzumab Optimization Trial in Breast CancerRegione Lombardia · unknown · Metastatic or Locally Advanced Breast Cancer · principal investigator
- Ph2NCT00636311 · A Phase II Study of IGEV +/- Bortezomib Before Hign Dose Consolidation in Relapsed/Refractory Hodgkin's LymphomaIstituto Clinico Humanitas · completed · Hodgkin Disease · principal investigator
- N/ANCT00491140 · Retrospective Study Assessing Molecular Features Predicting Response to CetuximabIstituto Clinico Humanitas · completed · Colorectal Neoplasms · study director
- Ph2NCT00490685 · Dose Escalation of Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)Istituto Clinico Humanitas · completed · Carcinoma, Hepatocellular · principal investigator
- Ph2NCT00410696 · Pegfilgrastim Versus Filgrastim After High-dose ChemotherapyArmando Santoro, MD · completed · Hematological Neoplasms, Tumors · study director
- Ph2NCT00407459 · Phase II Study of Bevacizumab, Pemetrexed and Carboplatin as First-Line Therapy in Malignant Pleural MesotheliomaArmando Santoro, MD · completed · Mesothelioma · principal investigator
- Ph2NCT00406601 · BAY-43-9006 in Advanced, Metastatic Soft Tissue SarcomasIstituto Clinico Humanitas · completed · Sarcoma, Soft Tissue · principal investigator
- Ph1/Ph2NCT00289809 · TLC D-99 and Ifosfamide in Metastatic Soft Tissue Sarcoma PatientsIstituto Clinico Humanitas · completed · Sarcoma, Soft Tissue · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:01 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.